Company · CIK 0001463361 · SIC 2834 — Pharmaceutical Preparations
Unity Biotechnology, Inc. · UBX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2018 MForm 4 → | Oct 12, 5:36 pm EDT | II Robert C. GoeltzChief Financial Officer | 5,000 | $3.43 | $17,150 | 101,348 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:26 pm EDT | Robert NelsenDirector, 10% Owner | 10,008,634 | — | — | 1,682,417 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:24 pm EDT | II Robert C. GoeltzChief Financial Officer | 1,630 | — | — | 96,348 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:23 pm EDT | Paul L BernsDirector | 3,261 | — | — | 3,261 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:23 pm EDT | Nathaniel E DavidPresident, Director | 1,297,810 | — | — | 2,278,656 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:22 pm EDT | Kristina BurowDirector | 10,008,634 | — | — | 1,682,417 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:20 pm EDT | Keith R LeonardChief Executive Officer, Director | 533,553 | — | — | 150,782 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:20 pm EDT | Jamie DananbergChief Medical Officer | 75,678 | — | — | 409,372 | — | plan? |
| May 7, 2018 CForm 4 → | May 7, 6:19 pm EDT | ARCH Venture Partners VII, LLC +610% Owner | 10,008,634 | — | — | 1,682,417 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2018 AForm 4 → | Dec 4, 4:07 pm EST | Margo R RobertsDirector | 50,661 | — | — | 50,661 | — | |
| Oct 10, 2018 MForm 4 → | Oct 12, 5:36 pm EDT | II Robert C. GoeltzChief Financial Officer | 5,000 | — | — | 120,620 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:26 pm EDT | Robert NelsenDirector, 10% Owner | 10,008,634 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:24 pm EDT | II Robert C. GoeltzChief Financial Officer | 1,630 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:23 pm EDT | Paul L BernsDirector | 3,261 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:23 pm EDT | Nathaniel E DavidPresident, Director | 1,297,810 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:22 pm EDT | Kristina BurowDirector | 10,008,634 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:20 pm EDT | Keith R LeonardChief Executive Officer, Director | 533,553 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:20 pm EDT | Jamie DananbergChief Medical Officer | 75,678 | — | — | 0 | — | |
| May 7, 2018 CForm 4 → | May 7, 6:19 pm EDT | ARCH Venture Partners VII, LLC +610% Owner | 10,008,634 | — | — | 0 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:28 pm EDT | Tamara TompkinsCorporate Secretary and GC | 30,508 | — | — | 30,508 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:27 pm EDT | Robert NelsenDirector, 10% Owner | 40,678 | — | — | 40,678 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:26 pm EDT | II Robert C. GoeltzChief Financial Officer | 30,508 | — | — | 30,508 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:25 pm EDT | Nathaniel E DavidPresident, Director | 47,458 | — | — | 47,458 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:24 pm EDT | Kristina BurowDirector | 40,678 | — | — | 40,678 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:21 pm EDT | Keith R LeonardChief Executive Officer, Director | 67,797 | — | — | 67,797 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:20 pm EDT | Jamie DananbergChief Medical Officer | 30,508 | — | — | 30,508 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:19 pm EDT | Graham K CooperDirector | 10,169 | — | — | 10,169 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:16 pm EDT | Dan MarquessChief Scientific Officer | 30,508 | — | — | 30,508 | — | |
| May 2, 2018 AForm 4 → | May 4, 6:14 pm EDT | Camille D SamuelsDirector | 40,678 | — | — | 40,678 | — |